AlphaGenome Atlas maps every possible human DNA change
On September 8 2026, Google DeepMind released AlphaGenome Atlas, a resource that predicts the molecular impact of every single-letter DNA variant in the human genome-about nine billion possible changes-stored in a one-petabyte database and made freely accessible via website, API, and Google Antigravity.
Short answer: On September 8 2026, Google DeepMind released AlphaGenome Atlas, a resource that predicts the molecular impact of every single-letter DNA variant in the human genome-about nine billion possible changes-stored in a one-petabyte database and made freely accessible via website, API, and Google Antigravity.
What is AlphaGenome Atlas and how does it predict DNA variant impacts?
On September 8, 2026, Google DeepMind unveiled AlphaGenome Atlas, a comprehensive resource that predicts the molecular impact of every single-letter DNA variant in the human genome. The platform contains predictions for roughly nine billion possible variants, offering researchers a unprecedented view of how genetic changes might influence biology at a molecular level. By turning an otherwise infeasible laboratory task into a computable map, the atlas aims to accelerate discoveries in genetics and disease research.
What is the storage size of the AlphaGenome Atlas dataset?
The underlying dataset is massive, occupying one petabyte of storage. This size exceeds thirty times the scale of the AlphaFold Database, which grew from about 190 000 experimental protein structures in 2022 to more than 200 million predicted structures covering nearly all known proteins. Like its predecessor, AlphaGenome Atlas is designed to be accessible, providing intuitive visualizations and a free-to-use website portal for academic users.
At the heart of the atlas is the AlphaGenome AI model, which was originally created to estimate how specific genetic variants affect biological processes. To give researchers a quick way to gauge importance, the team introduced the AlphaGenome Variant Impact (AVI) score. This single number merges the output of AlphaGenome with that of AlphaMissense, a model focused on protein-altering changes, allowing users to rank variants and interpret their effects simultaneously. Each AVI score is further broken down into feature attributions that highlight which biological features, such as particular aspects of gene regulation or protein impact, drive the prediction.
Beyond the score, the atlas supplies a suite of interconnected tools. It includes thousands of molecular effect predictions for each variant, spanning hundreds of human and mouse cell types and tissues. Researchers can also explore a library of over 2 500 recurrent DNA sequence motifs, which serve as the “words” of the genome and show where these patterns occur. These resources are linked so that a variant can be traced directly to the functional DNA sequences it disrupts, facilitating deeper analysis of regulatory mechanisms.
How can I access and use the AlphaGenome Atlas?
Access to AlphaGenome Atlas is provided through several channels. Users can browse the data via the website portal, query it programmatically through an API, or employ it as a skill within Google Antigravity, the company’s agentic development platform. The free availability aims to lower the barrier for scientists who lack extensive computational expertise, much like the AlphaFold Database did for structural biology.
Early adopters have already put the atlas to work. External collaborators reported using it to pinpoint and experimentally verify key variants in unsolved rare disease cases. In other projects, the resource helped uncover rare variants linked to common traits, demonstrating its utility for both rare and widespread conditions. These validations suggest that the predictive map can generate hypotheses that are testable in the lab, shortening the path from data to discovery.
For professionals who build or apply AI systems, the release highlights how large-scale precomputation can transform a model from a case-by-case tool into a broad reference infrastructure. It shows the value of coupling domain-specific AI with curated, easily navigable data collections, and it underscores the importance of providing complementary scores and attributions that aid interpretation. Researchers and engineers should consider how similar strategies might be applied to other complex biological or chemical spaces.
Readers interested in leveraging the atlas should start by exploring the website portal to familiarize themselves with the layout and visualization options. Developers can experiment with the API to integrate variant impact scores into existing pipelines, while teams using Google Antigravity can add the atlas as a skill to enable agent-driven genome analysis. As with any powerful predictive resource, users are reminded to validate AI-generated hypotheses experimentally and to remain mindful of ethical implications when working with human genetic data.
Frequently asked questions
What is AlphaGenome Atlas and when was it released?
AlphaGenome Atlas is a comprehensive resource unveiled by Google DeepMind on September 8, 2026, that predicts the molecular impact of every single-letter DNA variant in the human genome, containing predictions for roughly nine billion possible variants.
How large is the dataset behind AlphaGenome Atlas and how does it compare to the AlphaFold Database?
The dataset occupies one petabyte of storage, which exceeds thirty times the scale of the AlphaFold Database that grew from about 190,000 experimental protein structures in 2022 to more than 200 million predicted structures covering nearly all known proteins.
What is the AlphaGenome Variant Impact (AVI) score and how is it used?
The AlphaGenome Variant Impact (AVI) score is a single number that merges the output of the AlphaGenome AI model with that of AlphaMissense, allowing users to rank variants and interpret their effects simultaneously, with further breakdown into feature attributions that highlight driving biological features.
How can researchers access and use AlphaGenome Atlas?
Researchers can browse the data via the website portal, query it programmatically through an API, or employ it as a skill within Google Antigravity, the company’s agentic development platform, with free availability aimed at lowering barriers for academic users.
Source: Google DeepMind
Related posts
Meta Delays Business Terms After Publisher AI Scraping Concerns
Meta has delayed enforcement of its new business terms by three weeks, moving the effective date from October 30 to November 20, after publishers worldwide objected that the changes could allow the company to scrape their content for AI training without compensation. The News/Media Alliance demanded a full rewrite, and European regulators have been asked to intervene. Meta says the extension provides time to clarify the terms and how its web crawlers operate.
Microsoft Claims AI Tool Diagnoses Conditions Four Times Better Than
Microsoft's Diagnostic Orchestrator, a GPT-5-powered multi-agent system, scored 83% on NEJM cases versus 36% for generalists with references, and 80% on real emergency records versus 47% for doctors. The system mimics clinical reasoning through iterative agent collaboration. Microsoft stresses this is a research prototype-no live patient testing yet-and clinical validation, regulatory clearance, and EHR integration remain unresolved before deployment.
Canva Launches Craft AI Model That Plans Designs Before Generating
Canva has launched Craft, its first proprietary AI image model, which uses a two-stage architecture to plan designs before generating pixels. The company claims this approach delivers superior precision, consistency, and control over complex compositions, including legible text and precise object placement. Trained on millions of Canva templates, Craft outputs up to 2K resolution across 30-plus aspect ratios and ranks fourth on the Design Arena leaderboard. It is available globally now